Aquestive Therapeutics, Inc. (AQST)

SEC filing

Aquestive Therapeutics, Inc.

AQST · CIK 1398733

4 · Sep 11, 2026 · Chief Commercial Officer Korczynski Sherry sold 8,750 shares at $5.22/share ($45,675); exercised options for 17.50K shares

Chief Commercial Officer Korczynski Sherry sold 8,750 shares at $5.22/share ($45,675); exercised options for 17.50K shares

PRIMARY DOCUMENT

xslF345X06/marketforms-73981.xmlSEC.gov

Graphics and non-inline formats (not embedded below).